NCT01554995View on ClinicalTrials.gov

A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

February 28, 2013

Conditions
Healthy
Interventions
DRUG

LCB01-0371

LCB01-0371 50mg (Cohort 1) 100mg (Cohort 2) 200mg (Cohort 3) 400mg (Cohort 4) 600mg (Cohort 5)

DRUG

Linezolid

Linezolid 600 mg (Cohort 9) none

Trial Locations (1)

138736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

LigaChem Biosciences, Inc.

INDUSTRY

NCT01554995 - A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study | Biotech Hunter | Biotech Hunter